MYC and cancer: In this study, Myc hypomorphism was imposed prior to focal activation of KRasG12D, from which we inferred that the protection afforded by Myc hypomorphism acted either before or after KRasG12D activation but prior to the transition from hyperplasia to invasive cancer.